Citations for
1MYC, PIM2, USP27X
Phosphorylation of USP27X by PIM2 promotes glycolysis and breast cancer progression via deubiquitylation of MYC.
Han X, Ren C, Lu C, Jiang A, Wang X, Liu L, Yu Z.
Oncogene. Aug;43(33):2493-2503. doi: 10.1038/s41388-024-03097-y. Epub 2024 Jul 5. 2024
2PIM1, PIM2, PIM3
The PIM family of serine/threonine kinases in cancer.
Narlik-Grassow M, Blanco-Aparicio C, Carnero A.
Med Res Rev 34(1):136-59. doi: 10.1002/med.21284. Epub 2013 Apr 10. Review. 2014
3EIF4B, PIM2
The over-expression of Pim-2 promote the tumorigenesis of prostatic carcinoma through phosphorylating eIF4B.
Ren K, Gou X, Xiao M, Wang M, Liu C, Tang Z, He W.
Prostate 73(13):1462-9. doi: 10.1002/pros.22693. Epub 2013 Jun 27. 2013
4PIM2
Activation of cell cycle arrest and apoptosis by the proto-oncogene Pim-2.
Levy D, Davidovich A, Zirkin S, Frug Y, Cohen AM, Shalom S, Don J.
PLoS One 7(4):e34736. doi: 10.1371/journal.pone.0034736. Epub 2012 Apr 10. 2012
5PIM2
PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma.
Gómez-Abad C, Pisonero H, Blanco-Aparicio C, Roncador G, González-Menchén A, Martinez-Climent JA, Mata E, Rodríguez ME, Muñoz-González G, Sánchez-Beato M, Leal JF, Bischoff JR, Piris MA.
Blood 118(20):5517-27. doi: 10.1182/blood-2011-03-344374. Epub 2011 Sep 21. 2011
6PIM2
The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells.
Asano J, Nakano A, Oda A, Amou H, Hiasa M, Takeuchi K, Miki H, Nakamura S, Harada T, Fujii S, Kagawa K, Endo I, Yata K, Sakai A, Ozaki S, Matsumoto T, Abe M.
Leukemia 25(7):1182-8. doi: 10.1038/leu.2011.60. Epub 2011 Apr 8. 2011
7CDKN1A, PIM2
Pim-2 phosphorylation of p21(Cip1/WAF1) enhances its stability and inhibits cell proliferation in HCT116 cells.
Wang Z, Zhang Y, Gu JJ, Davitt C, Reeves R, Magnuson NS.
Int J Biochem Cell Biol 42(6):1030-8. doi: 10.1016/j.biocel.2010.03.012. Epub 2010 Mar 20. 2010
8PIM2
Serine/threonine kinase Pim-2 promotes liver tumorigenesis induction through mediating survival and preventing apoptosis of liver cell.
Gong J, Wang J, Ren K, Liu C, Li B, Shi Y.
J Surg Res 153(1):17-22. doi: 10.1016/j.jss.2008.03.033. Epub 2008 Apr 22. 2009
9PIM1, PIM2, PIM3
Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels.
Morishita D, Katayama R, Sekimizu K, Tsuruo T, Fujita N.
Cancer Res 68(13):5076-85. doi: 10.1158/0008-5472.CAN-08-0634. 2008
10PIM1, PIM2
Pim-1 and Pim-2 kinases are required for efficient pre-B-cell transformation by v-Abl oncogene.
Chen JL, Limnander A, Rothman PB.
Blood 111(3):1677-85. Epub 2007 Nov 27. 2008
11PIM2
PIM-2 is an independent regulator of chondrocyte survival and autophagy in the epiphyseal growth plate.
Bohensky J, Shapiro IM, Leshinsky S, Watanabe H, Srinivas V.
J Cell Physiol 213(1):246-51. 2007
12PIM1,PIM2,PIM3
Pim kinases phosphorylate multiple sites on Bad and promote 14-3-3 binding and dissociation from Bcl-XL.
Macdonald A, Campbell DG, Toth R, McLauchlan H, Hastie CJ, Arthur JS.
BMC Cell Biol 7:1. 2006
13PIM1,PIM2,PIM3
Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors.
Mikkers H, Nawijn M, Allen J, Brouwers C, Verhoeven E, Jonkers J, Berns A.
Mol Cell Biol 24(13):6104-15. 2004
14BAD, PIM2
The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death.
Yan B, Zemskova M, Holder S, Chin V, Kraft A, Koskinen PJ, Lilly M.
J Biol Chem 278(46):45358-67. Epub 2003 Sep 03. 2003
15PIM1, PIM2, SOCS1
Pim serine/threonine kinases regulate the stability of Socs-1 protein.
Chen XP, Losman JA, Cowan S, Donahue E, Fay S, Vuong BQ, Nawijn MC, Capece D, Cohan VL, Rothman P.
Proc Natl Acad Sci U S A 99(4):2175-80. 2002
16PIM2
The human Pim-2 proto-oncogene and its testicular expression.
Baytel D, et al.
Biochim Biophys Acta 1442(2-3):274-85 1998